New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2013
05:28 EDTQGEN, GEQIAGEN's KRAS companion diagnostic kit adopted by GE Healthcare's Clarient
QIAGEN (QGEN) announced that Clarient, a GE Healthcare (GE) company, has adopted the use of the therascreen KRAS RGQ PCR Kit as a companion diagnostic to guide the use of Erbitux as a treatment in patients with metastatic colorectal cancer. Clarient, with a customer base of more than 2,000 pathologists, oncologists, clinical laboratories and hospitals, selected QIAGEN's therascreen KRAS test and QIAGEN's Rotor-Gene Q MDx instrument following the FDA approval of the test in July 2012. Clarient joins a rapidly growing number of laboratories switching from laboratory-developed tests to the FDA-approved therascreen KRAS test for diagnostic testing for late stage colorectal cancer.
News For QGEN;GE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
January 23, 2015
07:48 EDTGEGeneral Electric reports Q4 orders $31.5B, Q4-end backlog $261B
Subscribe for More Information
06:35 EDTGEGeneral Electric reports Q4 EPS 56c, consensus 55c
Reports Q4 revenue $42.0B, consensus $42.16B
January 22, 2015
15:32 EDTGENotable companies reporting before tomorrow's open
Subscribe for More Information
15:21 EDTGEGeneral Electric technical comments ahead of results
Subscribe for More Information
12:16 EDTGEEarnings Preview: Analyst sentiment positive ahead of General Electric report
Subscribe for More Information
10:03 EDTGEOn the Fly: Analyst Initiation Summary
Subscribe for More Information
08:02 EDTGEGE Capital's TMT financing business says completed over 50 transactions in 2014
Subscribe for More Information
06:23 EDTGEGE to pay $464M more in Alstom energy assets deal, WSJ reports
Subscribe for More Information
January 21, 2015
16:13 EDTGEGeneral Electric initiated with a Buy at UBS
Target $30.
12:39 EDTGEGeneral Electric January weekly volatility elevated into Q4 and outlook
Subscribe for More Information
January 20, 2015
17:26 EDTGEGeneral Electric awarded $325M government contract
Subscribe for More Information
11:23 EDTGEEU to decide on GE, Alstom deal by February 23, Reuters reports
Antitrust regulators in the European Union will decide by February 23 whether to approve General Electric's (GE) planned acquisition of most of Alstom's (ALSMY) power equipment unit, Reuters reports. French authorities have already approved the planned deal after GE agreed to create jobs and form an energy joint venture with Alstom. Reference Link
06:48 EDTGEGE financing A350 jet with Rolls-Royce engine, Reuters reports
Subscribe for More Information
January 15, 2015
06:01 EDTGEMcDermott and GE launch io oil & gas consulting
McDermott (MDR) and GE Oil & Gas (GE) launched io oil & gas consulting, a new independent venture to transform front-end offshore field development. io will consider the full field as one system and have the technical insight to develop every aspect of the front-end solution. McDermott’s investment in io aligns with the company’s strategy to become more client-focused and responsive to operators’ challenges.
05:22 EDTGEGE Oil & Gas, McDermott launch io oil & gas consulting
Subscribe for More Information
January 12, 2015
09:31 EDTQGENTokai Pharmaceuticals announces collaboration with QIAGEN
Subscribe for More Information
05:36 EDTQGENQIAGEN announces regulatory registration of lung cancer companion diagnostic
Subscribe for More Information
January 11, 2015
15:20 EDTQGENQIAGEN expects to meet 2014 guidance ex-charges
Subscribe for More Information
15:16 EDTQGENQIAGEN to take Q4 charges of $41M for acquisition, restructuring
QIAGEN said that following its acquisition of the Enzyme Solutions Unit from Enzymatics, it will take a business integration and acquisition-related pre-tax charge on operating income in Q4 of approximately $21M, or 6c per share of adjusted diluted EPS, and of which $18M are non-cash items. These charges, which will be excluded from adjusted results, involve actions to reduce overlapping activities and sites, including the closing of the Gaithersburg, Maryland, site. In addition, following a review to further improve efficiency and effectiveness, QIAGEN will now take a restructuring-related pre-tax charge on operating income in Q4 of approximately $26M, or 8 per share, of which $20M are non-cash items. In line with QIAGEN's policy, the restructuring charges, which primarily involve the impairment of various technology-related assets, will not be excluded from adjusted results.
15:12 EDTQGENQIAGEN acquires Enzyme Solutions Unit of Enzymatics
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use